Predictive model for the Migraine-ACT questionnaire in primary care

Current Medical Research and Opinion

Volumn 23, Issue 12, 2007, Pages 3033-3039

  Pascual, Julio ^a   Láinez, Miguel J A ^b   Baos, Vicente ^c   García, María Luisa ^d   López Gil, Arturo ^e  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c CS Collado Villalba   (Spain)

^d CS 'Mendiguchía Carriche   (Spain)

^e AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Migraine; Migraine Assessment of Current Therapy (Migraine ACT) questionnaire; Primary care; Treatment needs

Indexed keywords

ADULT; ARTICLE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE ASSESSMENT OF CURRENT THERAPY QUESTIONNAIRE; MODEL; MORBIDITY; OPEN STUDY; PATIENT SATISFACTION; PREDICTIVE VALIDITY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PRIMARY HEALTH CARE; PROGNOSIS; QUESTIONNAIRES;

EID: 37749036473     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X242791     Document Type: Article

References (33)

1. Stovner LJ, Zwart JA, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol 2006;13:333-45
2. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57
3. Morillo LE, Alarcon F, Aranaga N, et al. Prevalence of migraine in Latin America. Headache 2005;45:106-17
4. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache 2003;43:19-26
5. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000;57:418-20
6. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain 2005;6:429-40
7. Lipton RB, Liberman JN, Kolodner KB, et al. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 2003;23:441-50
8. Santanello NC, Davies G, Allen C, et al. Determinants of migraine-specific quality of life. Cephalalgia 2002;22:680-5
9. Vicente-Herrero T, Burke TA, Lainez MJ. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective. Curr Med Res Opin 2004;20:1805-14
10. Lipton RB, Bigal ME, Kolodner K, et al. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003;23:429-40
11. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159:813-8
12. MacGregor EA, Brandes J, Eikermann A, Giammarco R. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey - Phase III. Curr Med Res Opin 2004;20:1143-50
13. Pradalier A, Auray JP, El Hasnaoui A, et al. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics 2004;22:985-99
14. Dueland AN, Leira R, Burke TA, et al. The impact of migraine on work, family, and leisure among young women - a multinational study. Curr Med Res Opin 2004;20:1595-604
15. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998;38:87-96
16. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002;58:885-94
17. Lucas C, Geraud G, Valade D, et al. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache 2006;46:715-25
18. Lipton RB, Scher AI, Steiner TJ, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003;60:441-8
19. Goadsby PJ. Recent advances in the diagnosis and management of migraine. Br Med J 2006;332:25-9
20. 1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002;22:633-58
21. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007;47:355-63
22. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001;41:638-45
23. Lipton RB, Stewart WF. Migraine in the United States: a review of epidemiology and health care use. Neurology 1993;43:S6-S10
24. Dowson AJ, Tepper SJ, Baos V, et al. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Curr Med Res Opin 2004;20:1125-35
25. Kilminster SG, Dowson AJ, Tepper SJ, et al. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire. Headache 2006;46:553-62
26. Osterhaus JT, Townsend RJ, Gandek B, Ware Jr JE. Measuring the functional status and well-being of patients with migraine headache. Headache 1994;34:337-43
27. Stewart WF, Lipton RB, Kolodner K, et al. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999;19:107-14
28. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 2001;56:S20-S28
29. Chatterton ML, Lofland JH, Shechter A, et al. Reliability and validity of the migraine therapy assessment questionnaire. Headache 2002;42:1006-15
30. Garcia ML, Baos V, Láinez MJA, et al. Responsiveness of Migraine-ACT and MIDAS questionnaires for assessing migraine therapy: a 3-month, open-label, prospective study of patients in primary care in Spain. Headache [accepted for publication]
31. Anon. The international classification of headache disorders, 2nd ed. Cephalalgia 2004;24(Suppl 1):9-160
32. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12:963-74
33. Ceballos Hernansanz MA, Sanchez Roy R, Cano Orgaz A, Lopez-Gil A. Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness. Clin Ther 2003;25:2053-69